Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Women'S Health (London, England)
|
June 24, 2015
The next steps in improving the outcomes of advanced ovarian cancer
Mark R Openshaw, Christina Fotopoulou, Sarah Blagden, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2005
Making sense of antisense
Laura Vidal, Sarah Blagden, Gerhardt Attard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 9, 2013
Feasibility of trials in ovarian cancer by line of therapy and platinum sensitivity
Roekshana Shaboodien, Nikolaos Diamantis, Sarah Blagden, et al.
Bjpsych Bulletin
|
September 23, 2020
A qualitative exploration of the barriers to and facilitators of clozapine monitoring in a secure psychiatric setting
Sarah Blagden, Jane Beenstock, Natalie Auld, et al.
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
|
July 31, 2015
A Comparative Study of Quality of Life in Persons With Irritable Bowel Syndrome and Inflammatory Bowel Disease
Sarah Blagden, Thomas Kingstone, Andrew Soundy, et al.
Gynecologic Oncology
|
December 14, 2011
A study of symptoms described by ovarian cancer survivors
Chara Stavraka, Amy Ford, Sadaf Ghaem-Maghami, et al.
Oncotarget
|
February 1, 2012
Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer
Helen M Coley, Eleftheria Hatzimichael, Sarah Blagden, et al.
BMJ Open
|
August 2, 2022
Interventions delivered in secondary or tertiary medical care settings to improve routine vaccination uptake in children and young people: a scoping review
Sarah Blagden, Kathryn Newell, Nareh Ghazarians, et al.
Journal of Medicinal Chemistry
|
January 30, 2014
Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development
Magdalena Slusarczyk, Monica Huerta Lopez, Jan Balzarini, et al.
Ebiomedicine
|
January 9, 2026
The circulating proteome and cancer risk: a systematic literature review and meta-analysis of 26 prospective studies with genetic validation
Alison Dillman, Haige An, Zhe Huang, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Women'S Health (London, England)
|
June 24, 2015
The next steps in improving the outcomes of advanced ovarian cancer
Mark R Openshaw, Christina Fotopoulou, Sarah Blagden, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2005
Making sense of antisense
Laura Vidal, Sarah Blagden, Gerhardt Attard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 9, 2013
Feasibility of trials in ovarian cancer by line of therapy and platinum sensitivity
Roekshana Shaboodien, Nikolaos Diamantis, Sarah Blagden, et al.
Bjpsych Bulletin
|
September 23, 2020
A qualitative exploration of the barriers to and facilitators of clozapine monitoring in a secure psychiatric setting
Sarah Blagden, Jane Beenstock, Natalie Auld, et al.
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
|
July 31, 2015
A Comparative Study of Quality of Life in Persons With Irritable Bowel Syndrome and Inflammatory Bowel Disease
Sarah Blagden, Thomas Kingstone, Andrew Soundy, et al.
Gynecologic Oncology
|
December 14, 2011
A study of symptoms described by ovarian cancer survivors
Chara Stavraka, Amy Ford, Sadaf Ghaem-Maghami, et al.
Oncotarget
|
February 1, 2012
Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer
Helen M Coley, Eleftheria Hatzimichael, Sarah Blagden, et al.
BMJ Open
|
August 2, 2022
Interventions delivered in secondary or tertiary medical care settings to improve routine vaccination uptake in children and young people: a scoping review
Sarah Blagden, Kathryn Newell, Nareh Ghazarians, et al.
Journal of Medicinal Chemistry
|
January 30, 2014
Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development
Magdalena Slusarczyk, Monica Huerta Lopez, Jan Balzarini, et al.
Ebiomedicine
|
January 9, 2026
The circulating proteome and cancer risk: a systematic literature review and meta-analysis of 26 prospective studies with genetic validation
Alison Dillman, Haige An, Zhe Huang, et al.
Page
of 4